GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (FRA:DMN) » Definitions » Institutional Ownership

Diamyd Medical AB (FRA:DMN) Institutional Ownership : 0.09% (As of Mar. 04, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Diamyd Medical AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Diamyd Medical AB's institutional ownership is 0.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Diamyd Medical AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Diamyd Medical AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Diamyd Medical AB Institutional Ownership Historical Data

The historical data trend for Diamyd Medical AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Institutional Ownership Chart

Diamyd Medical AB Historical Data

The historical data trend for Diamyd Medical AB can be seen below:

2024-03-31 2024-04-30 2024-05-31 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31
Institutional Ownership 0.01 0.01 0.01 0.01 0.02 0.07 0.07 0.06 0.08 0.09

Diamyd Medical AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Diamyd Medical AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (FRA:DMN) » Definitions » Institutional Ownership
Comparable Companies
OSTO:BINV OSTO:EGTX OSTO:HNSA OSTO:GENO OSTO:VICO OSTO:XSPRAY OSTO:SYNACT OSTO:SANION OSTO:IRLAB A OSTO:ABLI VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
DMYD B:Sweden
Address
Kungsgatan 29, Stockholm, SWE, SE-111 56
Website
https://www.diamyd.com
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.